Neil B Desai

Neil B Desai

UNVERIFIED PROFILE

Are you Neil B Desai?   Register this Author

Register author
Neil B Desai

Neil B Desai

Publications by authors named "Neil B Desai"

Are you Neil B Desai?   Register this Author

30Publications

1173Reads

45Profile Views

Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer?

Eur Urol 2019 Dec 14;76(6):740-742. Epub 2019 Aug 14.

Departments of Urology and Radiology, University of Texas Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.07.050DOI Listing
December 2019

Prostate brachytherapy procedural training: incorporation of related procedures in resident training and competency assessment.

J Contemp Brachytherapy 2019 Dec 16;11(6):601-606. Epub 2019 Dec 16.

Department of Radiation Oncology, Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, Dallas, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2019.90984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964344PMC
December 2019

Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.

Pract Radiat Oncol 2019 Nov 4;9(6):e528-e533. Epub 2019 Jun 4.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.05.013DOI Listing
November 2019

Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.

Clin Genitourin Cancer 2019 08 26;17(4):e768-e771. Epub 2019 Apr 26.

Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.04.005DOI Listing
August 2019

Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.

Future Oncol 2018 Nov 25;14(26):2773-2788. Epub 2018 Jun 25.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2280 Inwood Road, Dallas, TX 75390-9303, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2018-0286
Publisher Site
http://dx.doi.org/10.2217/fon-2018-0286DOI Listing
November 2018

Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.

Med Dosim 2017 Winter;42(4):341-347. Epub 2017 Jul 31.

Department of Radiation Oncology, Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.meddos.2017.07.002DOI Listing
August 2018

Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.

Int J Radiat Oncol Biol Phys 2018 04 31;100(5):1126-1132. Epub 2018 Jan 31.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.01.041DOI Listing
April 2018

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

Br J Radiol 2017 Feb 23;90(1070):20160500. Epub 2016 Dec 23.

Department of Radiation Oncology, Southwestern Medical Center, University of Texas, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20160500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685107PMC
February 2017

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.

J Clin Oncol 2016 Jan 5;34(2):123-9. Epub 2015 Oct 5.

Kimberly L. Johung, Sarah Goldberg, James B. Yu, Veronica L. Chiang, and Joseph N. Contessa, Yale University School of Medicine, New Haven, CT; Norman Yeh, Brian D. Kavanagh, and D. Ross Cambidge, University of Colorado Comprehensive Cancer Center, Aurora, CO; Neil B. Desai and Kathryn Beal, Memorial Sloan Kettering Cancer Center, New York, NY; Terence M. Williams and Tim Lautenschlaeger, Ohio State University, Columbus, OH; Nils D. Arvold, Dana-Farber/Brigham and Women's Hospital, Boston, MA; and Matthew S. Ning, Albert Attia, and Christine M. Lovly, Vanderbilt University School of Medicine, Nashville, TN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/09/29/JCO.2015.62
Web Search
http://jco.ascopubs.org/content/34/2/123.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.0138
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.0138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070549PMC
January 2016

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.

Gynecol Oncol 2014 Oct 30;135(1):49-53. Epub 2014 Jul 30.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.07.097DOI Listing
October 2014

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

Gynecol Oncol 2013 Dec 20;131(3):604-8. Epub 2013 Sep 20.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.09.019DOI Listing
December 2013

Bexarotene and erlotinib for aerodigestive tract cancer.

J Clin Oncol 2005 Dec;23(34):8757-64

Hematology/Oncology Section, Department of Medicine, Norris Cotton Cancer Center, Lebanon, NH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.9521DOI Listing
December 2005

Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.

Clin Cancer Res 2004 Apr;10(7):2570-7

Norris Cotton Cancer Center, and Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.ccr-03-0271DOI Listing
April 2004